All Stories

  1. Thermodynamic Signatures of Blood Plasma Proteome in Neurodegenerative Pathologies
  2. Eficacia en la vida real del fingolimod en pacientes con esclerosis múltiple en Bulgaria
  3. Platelets’ Nanomechanics and Morphology in Neurodegenerative Pathologies
  4. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
  5. Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications
  6. Morphometry and Stiffness of Red Blood Cells—Signatures of Neurodegenerative Diseases and Aging
  7. Red Blood Cells’ Thermodynamic Behavior in Neurodegenerative Pathologies and Aging
  8. The development and use of the European academy of neurology guideline on palliative care in advanced progressive multiple sclerosis
  9. Translation, adaptation and validation of the Bulgarian version of the King’s Parkinson’s Disease Pain Scale
  10. Clinical Correlation between Hormonal Status and Autonomic Nervous System Function in Patients with Fibromyalgia
  11. Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description
  12. Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
  13. EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis
  14. Neurophysiological Findings in Chronic Pain Syndromes
  15. Repetitive Transcranial Magnetic Stimulation over Two Target Areas, Sham Stimulation and Topiramate in the Treatment of Chronic Migraine
  16. Pitfals in recognition and management of trigeminal neuralgia
  17. Palliative care in multiple sclerosis: European guideline
  18. EAN guideline on palliative care of people with severe, progressive multiple sclerosis
  19. Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures – Authors' reply
  20. Update on the Management of Parkinson’s Disease for General Neurologists
  21. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
  22. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
  23. Novel Approach for Objective Quantification of Locomotor Disturbaces in Low Back Pain
  24. Neutralizing Antibodies against Interferon‑beta in Bulgarian Adolescent Multiple Sclerosis Patients
  25. Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis
  26. Do Binding Antibodies Predict Neutralizing Antibody Development in Multiple Sclerosis Patients?
  27. Starvation, Strachan's syndrome, and postgastroplasty syndrome
  28. Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes
  29. F-Wave in the Upper Extremities of Patients with Primary Torsion Dystonia
  30. Serum levels of EBVNA-IgG and EBVCA-IgG in patients with multiple sclerosis
  31. Trigeminal Nerve Reflexes in Chronic Pain Syndromes
  32. Back pain
  33. Back pain
  34. Trigeminal Neuralgia
  35. Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
  36. ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study
  37. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
  38. Diagnostic value of combinations of symptoms of migraine and tension-type headache included in the diagnostic criteria for children and adolescents in the international classification of headache disorders 2nd edition
  39. Chromosomal radiosensitivity in patients with multiple sclerosis
  40. How Does Fingolimod (Gilenya®) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?
  41. Evaluation of diagnostic and prognostic value of clinical characteristics of Migraine and Tension type headache included in the diagnostic criteria for children and adolescents in International Classification of Headache Disorders - second edition
  42. Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group
  43. Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
  44. Prevalence of Dementia and Mild Cognitive Impairment in a Bulgarian Urban Population
  45. A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. A multicentre European and Latin American study
  46. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
  47. Implementation and impact of headache guidelines
  48. Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
  49. Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing—remitting multiple sclerosis
  50. A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
  51. Transient Mutism and Pathologic Laughter in the Course of Cerebellitis
  52. Mechanisms of tizanidine action on spasticity
  53. Mechanisms of baclofen action on spasticity
  54. Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients wi...
  55. Determination of plasma aminothiols by high performance liquid chromatography after precolumn derivatization with N-(2-acridonyl)maleimide
  56. P013 Neurophysiological study on facial F-waves in patients with primary headache and with Parkinson's disease
  57. P234 Monitoring of drug efficacy on different types of tremor in Parkinson's disease
  58. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
  59. Therapeutic Use of Nicergoline
  60. S.01.02 Tension-type headache
  61. 1.184 Cognitive impairments in patients with early Parkinson's disease
  62. Abnormal Modulatory Influence of Diffuse Noxious Inhibitory Controls in Migraine and Chronic Tension-Type Headache Patients
  63. The epidemiology of multiple sclerosis in Europe
  64. International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis
  65. Acute reversible parkinsonism in Epstein–Bbarr virus–related encephalitis lethargica‐like illness
  66. Pain and tension-type headache: a review of the possible pathophysiological mechanisms
  67. Lower limb SSEP changes in stroke—predictive values regarding functional recovery
  68. Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine.
  69. Trigemino-Cervical Reflex in Patients with Headache
  70. Clinical and electromyographic assessment of essential tremor treatment
  71. Antiphospholipid syndrome and dystonia-parkinsonism
  72. Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine
  73. Antiphospholipid syndrome and dystonia-parkinsonism
  74. Electromyographic differentiation of tremors
  75. A cross-over clinical and electromyographic assessment of treatment for parkinsonian tremor
  76. Clinical and electromyographic examinations of patients with tremor after chronic occupational lead exposure
  77. Antiphospholipid syndrome and dystonia–parkinsonism. A case report
  78. Prevalence of Parkinson’s Disease in Bulgaria
  79. Effects of Sleep on Spinal Nociceptive Reflexes in Humans
  80. Clinical and electromyographic examinations of Parkinsonian tremor
  81. Asymmetrical reduction of the nociceptive flexion reflex threshold in cluster headache
  82. Asymmetrical Reduction of the Nociceptive Flexion Reflex Threshold in Cluster Headache
  83. Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial
  84. Effects of hypnosis on diffuse noxious inhibitory controls
  85. Clinical and electromyographic characteristics of tremor in patients with depression
  86. Clinical and Electromyographic Examinations of Patients with Essential Tremor
  87. Prevalence of Parkinson’s Disease in Bulgarian Gypsies
  88. Neurophysiological approach to the study of cluster headache
  89. Different effect of high doses of naloxone on spinal reflexes in normal subjects and chronic paraplegic patients
  90. Prevalence of Multiple Sclerosis in Gypsies and Bulgarians
  91. Contralateral hemi-parkinsonism and atypical tremor after stroke (a case report)
  92. Parkinsonian Syndrome as a Neurological Manifestation of Behcet's Disease
  93. 1-02-06 Differential diagnosis of amyotrophic lateral sclerosis and similar syndromes
  94. Prevalence of Multiple Sclerosis in Bulgaria
  95. P169 Differential diagnosis of limb girdle syndromes
  96. Writer’s Cramp and Tremor Due to Brain Tumor
  97. Vestibular and auditory influences on segmental motoneuron excitability — a comparative study
  98. Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy and Skin Changes (Poems) Syndrome
  99. A comparative study of methods for estimation of presynaptic inhibition
  100. A Comparison of Methods to Assess the Excitability of Lower Motoneurones